Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
J Immunol ; 174(1): 367-75, 2005 Jan 01.
Article in English | MEDLINE | ID: mdl-15611260

ABSTRACT

The BCR-ABL1 kinase expressed in acute lymphoblastic leukemia (ALL) drives malignant transformation of pre-B cells and prevents further development. We studied whether inhibition of BCR-ABL1 kinase activity using STI571 can relieve this differentiation block. STI571 treatment of leukemia patients induced expression of the Ig L chain-associated transcription factors IRF4 and SPIB, up-regulation of RAG1 and RAG2, Ckappa and Clambda germline transcription, and rearrangement of Ig kappa L chain (IGK) and Ig lambda L chain (IGL) genes. However, STI571-treated pre-B ALL cells expressed lambda L, but almost no kappa L chains. This could be explained by STI571-induced rearrangement of the kappa-deleting element (KDE), which can delete productively rearranged Vkappa-Jkappa joints. Amplifying double-strand breaks at recombination signal sequences within the IGK, KDE, and IGL loci revealed a coordinated sequence of rearrangement events induced by STI571: recombination of IGK gene segments was already initiated within 1 h after STI571 treatment, followed by KDE-mediated deletion of Vkappa-Jkappa joints 6 h later and, ultimately, IGL gene rearrangement after 12 h. Consistently, up-regulation of Ckappa and Clambda germline transcripts, indicating opening of IGK and IGL loci, was detected after 1 and 6 h for IGK and IGL, respectively. Continued activity of the recombination machinery induced secondary IGK gene rearrangements, which shifted preferential usage of upstream located Jkappa- to downstream Jkappa-gene segments. Thus, inhibition of BCR-ABL1 in pre-B ALL cells 1) recapitulates early B cell development, 2) directly shows that IGK, KDE, and IGL genes are rearranged in sequential order, and 3) provides a model for Ig L chain gene regulation in the human.


Subject(s)
B-Lymphocytes/drug effects , Gene Rearrangement, B-Lymphocyte, Light Chain/drug effects , Precursor Cell Lymphoblastic Leukemia-Lymphoma/genetics , Protein Kinase Inhibitors/therapeutic use , Stem Cells/drug effects , B-Lymphocytes/metabolism , Benzamides , DNA Primers , DNA-Binding Proteins/drug effects , DNA-Binding Proteins/metabolism , Flow Cytometry , Fusion Proteins, bcr-abl , Gene Expression Regulation, Neoplastic , Gene Rearrangement, B-Lymphocyte, Light Chain/genetics , Guanine Nucleotide Exchange Factors/drug effects , Guanine Nucleotide Exchange Factors/metabolism , Homeodomain Proteins/drug effects , Homeodomain Proteins/metabolism , Humans , Imatinib Mesylate , Immunoglobulins/genetics , Nuclear Proteins , Piperazines/therapeutic use , Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy , Protein-Tyrosine Kinases/antagonists & inhibitors , Pyrimidines/therapeutic use , Reverse Transcriptase Polymerase Chain Reaction , Stem Cells/metabolism , Transcription Factors/drug effects , Transcription Factors/metabolism
2.
Eur J Immunol ; 33(2): 334-41, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12548564

ABSTRACT

TRANCE (TNF-related activation-induced cytokine)-deficient mice completely lack osteoclasts, and develop severe osteopetrosis. These mice also show a defect in their pre-B cell differentiation. In the present study, the expression of TRANCE was examined in pre-B cell lines using flow cytometry and reverse transcription-PCR. Three pre-B cell lines, 18-81, B3P816-1, and 38B9, expressed TRANCE on their surface, and two pre-B cell lines, 7OZ/3 and NFS5, at the late pre-B cell stage, expressed it at low levels, although their mRNA expression was normal. Another pre-B cell line, 38-C-13, at the intermediate stage between pre-B and immature B cells, did not express TRANCE. The IL-7-dependent pre-B cell line PreBR, which expresses the pre-B cell receptor on the cell surface, also expressed TRANCE. When differentiation of PreBR cells was induced in vitro by removing IL-7 from cultures, TRANCE expression dropped; it was restored by the addition of IL-7, suggesting that TRANCE functions in cooperation with IL-7. To examine the function of TRANCE, we introduced the TRANCE gene into PreBR cells and established two transfectants that constitutively expressed TRANCE, even in the absence of IL-7. In these transfectants, after removal of IL-7, the number of cells that succeeded in kappa chain rearrangement was decreased to one third; and CD40 expression decreased to less than one tenth. Moreover, the percentage of cells in the S/G2/M phase was increased by 50% over the mock transfectant. These findings indicate that, before kappa chain rearrangement occurs, TRANCE together with IL-7 induces pre-B cells to proliferate and makes this rearrangement more efficient.


Subject(s)
B-Lymphocytes/drug effects , Carrier Proteins/physiology , Hematopoietic Stem Cells/drug effects , Interleukin-7/pharmacology , Membrane Glycoproteins/physiology , Animals , B-Lymphocytes/cytology , CD40 Antigens/biosynthesis , CD40 Antigens/genetics , Carrier Proteins/genetics , Cell Cycle/drug effects , Cell Division/drug effects , Cell Line/drug effects , Gene Expression Regulation/drug effects , Gene Rearrangement, B-Lymphocyte, Light Chain/drug effects , Glycoproteins/metabolism , Hematopoietic Stem Cells/cytology , Immunoglobulin kappa-Chains/genetics , Membrane Glycoproteins/genetics , Mice , Mice, Inbred BALB C , Osteoprotegerin , RANK Ligand , Receptor Activator of Nuclear Factor-kappa B , Receptors, Cytoplasmic and Nuclear/metabolism , Receptors, Tumor Necrosis Factor , Recombinant Fusion Proteins/metabolism , Recombinant Fusion Proteins/physiology , Signal Transduction , Transfection
3.
Nat Immunol ; 4(1): 31-7, 2003 Jan.
Article in English | MEDLINE | ID: mdl-12469118

ABSTRACT

Abelson murine leukemia virus-transformed cell lines have provided a critical model system for studying the regulation of B cell development. However, transformation by v-Abl blocks B cell development, resulting in the arrest of these transformants in an early pre-B cell-like state. We report here that treatment of Abelson virus-transformed pre-B cell lines with the small molecule Abl kinase inhibitor (STI571) results in their differentiation to a late pre-B cell-like state characterized by induction of immunoglobulin (Ig) light chain gene rearrangement. DNA microarray analyses enabled us to identify two genes inhibited by v-Abl that encode the Igk 3' enhancer-binding transcription factors Spi-B and IRF-4. We show that enforced expression of these two factors is sufficient to induce germline Igk transcription in Abelson-transformed pro-B cell lines. This suggests a key role for these factors, and perhaps for c-Abl itself, in the regulated activation of Ig light chain gene rearrangement.


Subject(s)
Abelson murine leukemia virus , B-Lymphocytes/cytology , B-Lymphocytes/virology , Oncogene Proteins v-abl/antagonists & inhibitors , Abelson murine leukemia virus/genetics , Abelson murine leukemia virus/pathogenicity , Animals , B-Lymphocytes/drug effects , B-Lymphocytes/immunology , Base Sequence , Benzamides , Cell Differentiation/drug effects , Cell Line, Transformed , DNA/genetics , DNA-Binding Proteins/genetics , Enzyme Inhibitors/pharmacology , Gene Expression Profiling , Gene Rearrangement, B-Lymphocyte, Light Chain/drug effects , Imatinib Mesylate , Mice , Oligonucleotide Array Sequence Analysis , Piperazines , Protein-Tyrosine Kinases/antagonists & inhibitors , Pyrimidines/pharmacology , Transcription Factors/genetics
4.
J Immunol ; 167(2): 866-74, 2001 Jul 15.
Article in English | MEDLINE | ID: mdl-11441093

ABSTRACT

Rearrangement of Ig H and L chain genes is highly regulated and takes place sequentially during B cell development. Several lines of evidence indicate that chromatin may modulate accessibility of the Ig loci for V(D)J recombination. In this study, we show that remodeling of V and J segment chromatin occurs before V(D)J recombination at the endogenous H and kappa L chain loci. In recombination-activating gene-deficient pro-B cells, there is a reorganization of nucleosomal structure over the H chain J(H) cluster and increased DNase I sensitivity of V(H) and J(H) segments. The pro-B/pre-B cell transition is marked by a decrease in the DNase I sensitivity of V(H) segments and a reciprocal increase in the nuclease sensitivity of Vkappa and Jkappa segments. In contrast, J(H) segments remain DNase I sensitive, and their nucleosomal organization is maintained in mu(+) recombination-activating gene-deficient pre-B cells. These results indicate that initiation of rearrangement is associated with changes in the chromatin structure of both V and J segments, whereas stopping recombination involves changes in only V segment chromatin. We further find an increase in histone H4 acetylation at both the H and kappa L chain loci at the pro-B cell stage. Although histone H4 acetylation appears to be an early change associated with B cell commitment, acetylation alone is not sufficient to promote subsequent modifications in Ig chromatin.


Subject(s)
Chromatin/genetics , Chromatin/metabolism , Gene Rearrangement, B-Lymphocyte, Heavy Chain , Gene Rearrangement, B-Lymphocyte, Light Chain , Genes, Immunoglobulin , Immunoglobulin Variable Region/genetics , Acetylation , Animals , B-Lymphocytes/cytology , B-Lymphocytes/enzymology , B-Lymphocytes/immunology , B-Lymphocytes/metabolism , Cell Differentiation/genetics , Cell Differentiation/immunology , Cell Line, Transformed , Chromatin/drug effects , Deoxyribonuclease I/metabolism , Gene Rearrangement, B-Lymphocyte, Heavy Chain/drug effects , Gene Rearrangement, B-Lymphocyte, Light Chain/drug effects , Genes, Immunoglobulin/drug effects , Genetic Markers/immunology , Histones/metabolism , Hydroxamic Acids/pharmacology , Immunoglobulin Joining Region/genetics , Immunoglobulin kappa-Chains/genetics , Lipopolysaccharides/pharmacology , Mice , Nucleosomes/genetics , Nucleosomes/metabolism , Recombination, Genetic/immunology , Stem Cells/metabolism , Tumor Cells, Cultured
5.
Mol Immunol ; 36(3): 177-85, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10403483

ABSTRACT

HB4C5 is a human antibody producing plasma B cell line that expresses the recombination activating gene-1 (RAG-1) and RAG-2 constitutively, but undergoes few secondary immunoglobulin gene rearrangements when cultured in fetal bovine serum-containing medium. Here, we found that depletion of serum from the culture media induces secondary VlambdaJlambda rearrangement in this cell line. To investigate the induction mechanism of secondary VlambdaJlambda rearrangement, we assessed the expression levels of RAG-1 and RAG-2 products, Vlambda germline transcription level and the amount of Vlambda signal broken ends (SBE) in HB4C5 cells cultured in serum-supplemented or serum-free medium. Western-blot analysis showed that the expression level for the RAG-1 and RAG-2 proteins was not affected by the serum depletion. Vlambda germline transcript was found to be constitutively expressed in HB4C5 cell line and this transcription level was not affected by the lack of serum. On the other hand, the amount of Vlambda SBE was shown to be increased in HB4C5 cells cultured in serum-free medium, suggesting that this increased formation of Vlambda SBE at least partly contributed to the enhanced occurrence of secondary VlambdaJlambda rearrangement in HB4C5 cells cultured in the serum-free condition. These results indicate that expression of RAG proteins and Vlambda germline transcription is not enough to undergo secondary VlambdaJlambda rearrangement in this cell line.


Subject(s)
Culture Media, Serum-Free/pharmacology , Gene Rearrangement, B-Lymphocyte, Light Chain , Immunoglobulin Variable Region/metabolism , Plasma Cells/metabolism , Burkitt Lymphoma , Gene Expression Regulation/immunology , Gene Rearrangement, B-Lymphocyte, Light Chain/drug effects , Genes, RAG-1/immunology , Homeodomain Proteins/biosynthesis , Homeodomain Proteins/genetics , Humans , Transcription, Genetic/immunology , Tumor Cells, Cultured
SELECTION OF CITATIONS
SEARCH DETAIL
...